These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 37530824)

  • 21. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
    McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
    J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Improvement of Specific Symptoms Predicts Subsequent Recovery in Bipolar Depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) Data.
    Mizushima J; Uchida H; Tada M; Suzuki T; Mimura M; Nio S
    J Clin Psychiatry; 2017 Feb; 78(2):e146-e151. PubMed ID: 28234437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antidepressant therapy for major depressive disorder: speed and probability of remission.
    Stewart JW; McGrath PJ; Blondeau C; Deliyannides DA; Hellerstein D; Norris S; Amat J; Pilowsky DJ; Tessier P; Laberge L; O'Shea D; Chen Y; Withers A; Bergeron R; Blier P
    J Psychiatr Res; 2014 May; 52():7-14. PubMed ID: 24485847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.
    Yatham LN; Vieta E; Goodwin GM; Bourin M; de Bodinat C; Laredo J; Calabrese J;
    Br J Psychiatry; 2016 Jan; 208(1):78-86. PubMed ID: 25999335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder.
    Zhang L; Zhang H; Lv LX; Tan Q; Xu X; Hu J; Zi L; Cooper J; Phansalkar A; Wang G
    Int J Bipolar Disord; 2022 Aug; 10(1):20. PubMed ID: 35909213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
    Szegedi A; Durgam S; Mackle M; Yu SY; Wu X; Mathews M; Landbloom RP
    Am J Psychiatry; 2018 Jan; 175(1):71-79. PubMed ID: 28946761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
    Keck PE; Calabrese JR; McQuade RD; Carson WH; Carlson BX; Rollin LM; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2006 Apr; 67(4):626-37. PubMed ID: 16669728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
    McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial.
    Kauer-Sant'Anna M; Frey BN; Fijtman A; Loredo-Souza AC; Dargél AA; Pfaffenseller B; Wollenhaupt-Aguiar B; Gazalle FK; Colpo GD; Passos IC; Bücker J; Walz JC; Jansen K; Ceresér KM; Bürke Bridi KP; Dos Santos Sória L; Kunz M; Pinho M; Kapczinski NS; Goi PD; Magalhães PV; Reckziegel R; Burque RK; de Azevedo Cardoso T; Kapczinski F
    J Psychopharmacol; 2019 Apr; 33(4):502-510. PubMed ID: 30835152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M; Calabrese JR; Sachs GS; Banov MD; Detke HC; Risser R; Baker RW; Chou JC; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression: A Randomized Clinical Trial.
    McGirr A; Vila-Rodriguez F; Cole J; Torres IJ; Arumugham SS; Keramatian K; Saraf G; Lam RW; Chakrabarty T; Yatham LN
    JAMA Netw Open; 2021 Mar; 4(3):e210963. PubMed ID: 33710288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical indicators for the use of antidepressants in the treatment of bipolar I depression.
    Fagiolini A; Frank E; Cherry CR; Houck PR; Novick DM; Buysse DJ; Kupfer DJ
    Bipolar Disord; 2002 Oct; 4(5):277-82. PubMed ID: 12479658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial.
    Shen Y; Zhao Q; Yu Y; Tan Y; Zhang H; Xu X; Wang Z; Li Y; Hu J; Zhong J; Li H
    J Affect Disord; 2019 Oct; 257():143-149. PubMed ID: 31301615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.